MISSION Therapeutics
MISSION Therapeutics is a Cambridge, Cambridgeshire-based biotechnology company offering a platform for the development of small molecule drugs that selectively target deubiquitylating enzymes.
8
Funding Rounds
$209.3m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ni*** Ma**** | - | - | - |
| St*** Ja***** | - | - | - |
| Xa**** Ja** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company MISSION Therapeutics has raised a total of $209.31m in funding over 8 rounds.
Key Insights:
- MISSION Therapeutics March 2024 Series B Funding Round: $32m
- MISSION Therapeutics July 2020 Series C Funding Round: $15m
- MISSION Therapeutics , July 2020: $15m
- MISSION Therapeutics February 2016 Series C Funding Round: $76m
- MISSION Therapeutics November 2013 Series B Funding Round: $25m
- MISSION Therapeutics Series B round: $30.31m
- MISSION Therapeutics funding round, August 2011: $10m
- MISSION Therapeutics August 2011 Series A Funding Round: $6m
MISSION Therapeutics March 2024 Series B Funding Round
$32m
MISSION Therapeutics July 2020 Series C Funding Round
$15m
MISSION Therapeutics , July 2020
$15m
MISSION Therapeutics February 2016 Series C Funding Round
$76m
MISSION Therapeutics November 2013 Series B Funding Round
$25m
MISSION Therapeutics Series B round
$30.31m
MISSION Therapeutics funding round, August 2011
$10m
MISSION Therapeutics August 2011 Series A Funding Round
$6m
Industries
MISSION Therapeutics is active in the following industries: